Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes

被引：9
|
作者：
Hickman, Ingrid J. [1 ]
Whitehead, Jonathan P. [1 ]
Prins, Johannes B. [1 ]
Macdonald, Graeme A. [1 ]
机构：
[1] Univ Queensland, Princess Alexandra Hosp, CDER, Woolloongabba, Qld 4102, Australia
来源：
DIABETES OBESITY & METABOLISM | 2007年 / 9卷 / 03期
关键词：
adiponectin; BMI; insulin resistance; liver injury; NAFLD;
D O I：
10.1111/j.1463-1326.2006.00604.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: The aim of the study was to investigate the relationship between the metabolic syndrome (MS), adiponectin and abnormal liver enzymes in patients with type 2 diabetes. Methods: Fasting serum was collected from 189 patients with type 2 diabetes, adiponectin was measure using radioimmunoassay and features of the MS were assessed. Results: Mean ALT was significantly higher in patients with the MS and higher ALT was associated with lower adiponectin levels. As the number of features of MS increased, ALT increased and adiponectin decreased independent of glycaemic control. Conclusion: Hypoadiponectinemia and the MS may be linked with liver injury in patients with type 2 diabetes.
引用
收藏
页码：438 / 440
页数：3
相关论文
共 50 条
  • [31] The role of leptin/adiponectin ratio in metabolic syndrome and diabetes
    Lopez-Jaramillo, Patricio
    Gomez-Arbelaez, Diego
    Lopez-Lopez, Jose
    Lopez-Lopez, Cristina
    Martinez-Ortega, Javier
    Gomez-Rodriguez, Andrea
    Triana-Cubillos, Stefany
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2014, 18 (01) : 37 - 45
  • [32] Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention
    Shishkova, V. N.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (01) : 109 - 114
  • [33] Variants of the Adiponectin Gene and Diabetic Microvascular Complications in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Wang, Hye Jin
    Kwon, Obin
    Kim, Kwang Joon
    Kim, Bum Seok
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (05): : 677 - 685
  • [34] Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 Diabetes and Erectile Dysfunction
    Elsaied, Moustafa A.
    Masallat, Doaa
    Abdel-Hamid, Ibrahim A.
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 13 (01)
  • [35] Evaluation of the serum visfatin and adiponectin levels in patients with type 2 diabetes mellitus
    Kara, Mehmet
    Uslu, Sema
    Kebapci, Nur
    Ozcelik, Eda
    Bal, Cengiz
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2014, 39 (02): : 181 - 187
  • [36] The role of adiponectin gene variants in glycemic control in patients with Type 2 diabetes
    Al-Azzam, Sayer I.
    Khabour, Omar F.
    Alzoubi, Karem H.
    Mukattash, Tareq L.
    Ghanma, Mais
    Saleh, Hanan
    ENDOCRINE RESEARCH, 2014, 39 (01) : 13 - 17
  • [37] Inflammatory Cytokines, Adiponectin, Insulin Resistance and Metabolic Control after Periodontal Intervention in Patients with Type 2 Diabetes and Chronic Periodontitis
    Sun, Wei-Lian
    Chen, Li-Li
    Zhang, Su-Zhan
    Wu, Yan-Min
    Ren, Yue-Zhong
    Qin, Guang-Ming
    INTERNAL MEDICINE, 2011, 50 (15) : 1569 - 1574
  • [38] Adiponectin and TNFα in relation to glucometabolic control in patients with type 2 diabetes mellitus
    Habib, Syed Shahid
    Al-khlaiwi, Thamir
    Al-khliwi, Huthayfah
    Habib, Syed Mohammad
    Habib, Syed Abubakar
    Habib, Syed Hamid
    Khan, Adeena
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (07) : 2741 - 2745
  • [39] Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes
    Retnakaran, R.
    Connelly, P. W.
    Maguire, G.
    Sermer, M.
    Zinman, B.
    Hanley, A. J. G.
    DIABETIC MEDICINE, 2007, 24 (03) : 245 - 252
  • [40] Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities
    Baden, M. Y.
    Yamada, Y.
    Obata, Y.
    Hosakawa, Y.
    Saisho, K.
    Tamba, S.
    Yamamoto, K.
    Umeda, M.
    Furubayashi, A.
    Tsukamoto, Y.
    Matsuzawa, Y.
    NUTRITION & DIABETES, 2011, 1 : e18 - e18
12345